Phenotype-genotype correlations in patients with Wilson's disease

Annals of the New York Academy of Sciences

Volumn 1315, Issue 1, 2014, Pages 1-5

  Ferenci, Peter ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

ATP7B mutations; Liver disease; Movement disorders; Wilson's disease

Indexed keywords

ARTICLE; ATP7B GENE; GENE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE PHENOTYPE CORRELATION; HOMOZYGOTE; HUMAN; LIVER DISEASE; LIVER FUNCTION; MUTATIONAL ANALYSIS; NEUROLOGIC DISEASE; PHENOTYPE; SEQUENCE ANALYSIS; SIBLING; WILSON DISEASE;

ATP7B MUTATIONS; LIVER DISEASE; MOVEMENT DISORDERS; WILSON'S DISEASE;

ADENOSINE TRIPHOSPHATASES; ADOLESCENT; ADULT; AGE OF ONSET; CATION TRANSPORT PROTEINS; CHILD; COPPER; DELAYED DIAGNOSIS; FEMALE; GENETIC ASSOCIATION STUDIES; HEPATOLENTICULAR DEGENERATION; HUMANS; MALE; MIDDLE AGED; MUTATION; SIBLINGS; YOUNG ADULT;

EID: 84900010540     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/nyas.12340     Document Type: Article

References (33)

1. Wilson, K.A. 1912. Progressive lenticular degeneration. A familial nervous disease associated with cirrhosis of the liver. Brain 34: 295-507.
2. Bramwell, B. 1916. 'Familial cirrhosis of the liver: four cases of acute fatal cirrhosis of the liver in the same family, the patients being nine, ten, fourteen years of age: suggested relationship to Wilson's progressive degeneration of the lenticular nucleus. Edinb. Med. J. 17: 90-99.
3. Sternlieb, I. & I.C.H. Scheinberg. 1972. Chronic hepatitis as a first manifestation of Wilson's disease. Ann. Intern. Med. 76: 59-74.
4. Sternlieb, I. 1992. Fraternal concordance of types of abnormal hepatocellular mitochondria in Wilson's disease. Hepatology. 16: 728-732.
5. Liggi, M., D. Murgia, A. Civolani, et al. 2013. The relationship between copper and steatosis in Wilson's disease. Clin. Res. Hepatol. Gastroenterol. 37: 36-40.
6. Roberts, E.A., B.H. Robinson & S. Yang. 2008. Mitochondrial structure and function in the untreated Jackson toxic milk (tx-j) mouse, a model for Wilson disease. Mol. Genet. Metab. 93: 54-65.
7. Stättermayer, A., H.P. Dienes, H. Hofer, et al. 2012. Association of PNPLA3 polymorphism with steatosis in patients with Wilson's disease. Hepatology 56(Suppl): 827A.
8. Kim, J.W., J.H. Kim, J.K. Seo, et al. 2013. Genetically confirmed Wilson disease in a 9-month old boy with elevations of aminotransferases. World J. Hepatol. 5: 156-159.
9. Ala, A., J. Borjigin, A. Rochwarger & M. Michael Schilsky. 2005. Wilson disease in septuagenarian siblings: raising the bar for diagnosis. Hepatology 41: 668-670.
10. Ferenci, P., A. Członkowska, U. Merle, et al. 2007. Late onset Wilson disease. Gastroenterology 132: 1294-1298.
11. Maier-Dobersberger, Th., P. Ferenci, C. Polli, et al. 1997. Detection of the His1069Gln mutation in Wilson disease by a rapid polymerase chain reaction. Ann. Intern. Med. 127: 21-26.
12. Scheinberg, I.H. & I. Sternlieb. 1984. Wilsońs disease. Major Problems in Internal Medicine. Vol. 23. Philadelphia: Saunders.
13. Merle, U., M. Schaefer, P. Ferenci & W. Stremmel. 2007. Clinical Presentation, diagnosis and long-term outcome of Wilson disease-a cohort study. Gut 56: 115-120.
14. Ferenci, P., K. Caca, G. Loudianos, et al. 2003. Diagnosis and phenotypic classification of Wilson disease. Final report of the proceedings of the working party at the 8th International Meeting on Wilson disease and Menkes disease, Leipzig/Germany, April 16-18, 2001. Liver Int. 23: 139-142.
15. Ferenci, P., K. Caca, G. Loudianos, et al2012. EASL Clinical Practice Guidelines: Wilsońs disease. J. Hepatol. 56: 671-685.
16. Ferenci, P. & E.A. Roberts. 2012. Defining Wilson disease phenotypes: from the patient to the bench and back again. Gastroenterology 142: 692-696.
17. Coffey, A.J., M. Durkie, S. Hague, et al. 2013. A genetic study of Wilson's disease in the United Kingdom. Brain. 136: 1476-1487.
18. Ferenci, P. 2006. Regional distribution of mutations of the ATP7B gene in patients with Wilson disease- impact on genetic testing. Hum. Genet. 120: 151-159.
19. Wu, Z.Y., N. Wang, M.T. Lin, et al. 2001. Mutation analysis and the correlation between genotype and phenotype of Arg778Leu mutation in chinese patients with Wilson disease. Arch. Neurol. 58: 971-976.
20. Barada, K., M. El-Atrache, I.I. El-Hajj, et al. 2010. Homozygous mutations in the conserved ATP hinge region of the Wilson disease gene: association with liver disease. J. Clin. Gastroenterol. 44: 432-439.
21. Lee, B.H., J.H. Kim, S.Y. Lee, et al. 2011. Distinct clinical courses according to presenting phenotypes and their correlations to ATP7B mutations in a large Wilson's disease cohort. Liver Int. 31: 831-839.
22. Houwen, R.H., J. Juyn, T.U. Hoogenraad, et al. 1995. H714Q mutation in Wilson disease is associated with late, neurological presentation. J. Med. Genet. 32: 480-482.
23. Merle, U., K.H. Weiss, C. Eisenbach, et al. 2010. Truncating mutations in the Wilson disease gene ATP7B are associated with very low serum ceruloplasmin oxidase activity and an early onset of Wilson disease. BMC Gastroenterol. 10: 8.
24. Okada, T., Y. Shiono, Y. Kaneko, et al. 2010. High prevalence of fulminant hepatic failure among patients with mutant alleles for truncation of ATP7B in Wilson's disease. Scand J. Gastroenterol. 45: 1232-1237.
25. Hofer, H., W. Weiss, C. Willheim, et al. 2013. Phenotype-genotype correlations in siblings of index patients with Wilson disease. J. Hepatol. 58: S559.
26. Chabik, G., T. Litwin & A. Członkowska. 2014. Concordance rates of Wilson's disease phenotype among siblings. J. Inherit. Metab. Dis. 37: 131-135.
27. Huster, D., A. Kühne, A. Bhattacharjee, et al. 2012. Diverse functional properties of Wilson disease ATP7B variants. Gastroenterology 142: 947-956.
28. Schiefermeier, M., H. Kollegger, C. Madl, et al. 2000. The impact of apolipoprotein E genotypes on phenotypic expression of Wilson's disease. Brain 123: 585-590.
29. Merle, U., W. Stremmel & R. Gessner. 2006. Influence of homozygosity for methionine at codon 129 of the human prion gene on the onset of neurological and hepatic symptoms in Wilson disease. Arch Neurol 63: 982-985.
30. Gromadzka, G., M. Rudnicka, G. Chabik, et al. 2011. Genetic variability in the methylenetetrahydrofolate reductase gene (MTHFR) affects clinical expression of Wilson's disease. J Hepatol 55: 913-919.
31. Cheng, T.F., S. Choudhuri & K. Muldoon-Jacobs. 2012. Epigenetic targets of some toxi-cologically relevant metals: a review of the literature. J. Appl. Toxicol. 32: 643-653.
32. Wilson disease mutation database: http://www.wilsondisease.med.ualberta.ca/database.asp (last accessed October 9, 2013).
33. Horslen, S. & S.H. Hahn. 2010. Genotype-phenotype correlation in Wilson disease. J. Clin. Gastroenterol. 44: 387-388.